PELVIC CLINICAL TARGET VOLUME DEFINITION IN HIGH-RISK PROSTATE CANCER USING SENTINEL NODE SPECT AND 18F-FCH PET-CT

被引：0
|
作者：
Vees, H. [1 ]
Steiner, C. [2 ]
Chouiter, A. [3 ]
Dipasquale, G. [1 ]
Zilli, T. [1 ]
Wissmeyer, M. [2 ]
Ratib, O. [2 ]
Buchegger, F. [2 ]
Miralbell, R. [1 ]
机构：
[1] Hop Univ Geneve, Geneva, Switzerland
[2] Hop Univ Geneve, Nucl Med, Geneva, Switzerland
[3] Hop Univ Geneve, Radiol, Geneva, Switzerland
来源：
RADIOTHERAPY AND ONCOLOGY | 2010年 / 96卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1155
引用
收藏
页码：S389 / S389
页数：1
相关论文
共 50 条
  • [21] PET-CT Improved High-risk Prostate Cancer Staging in Trial
    Abbasi, Jennifer
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (18): : 1764 - 1764
  • [22] Intensity modulated radiotherapy for high risk prostate cancer based on sentinel node optimized target volume definition
    不详
    EUROPEAN UROLOGY SUPPLEMENTS, 2005, 4 (03) : 41 - 41
  • [23] Intensity modulated radiotherapy for high risk prostate cancer based on sentinel node optimized target volume definition
    Ganswindt, U
    Paulsen, F
    Glocker, S
    Alber, M
    Corvin, S
    Hundt, I
    Bamberg, M
    Belka, C
    RADIOTHERAPY AND ONCOLOGY, 2006, 78 : S40 - S41
  • [24] Pairwise comparison of 18F-FDG and 18F-FCH PET/CT in prostate cancer patients with rising PSA and known or suspected second malignancy
    Kit, Nicolas How
    Dugue, Audrey E.
    Sevin, Emmanuel
    Allouache, Nedjla
    Lesaunier, Francois
    Joly, Florence
    Aide, Nicolas
    NUCLEAR MEDICINE COMMUNICATIONS, 2016, 37 (04) : 348 - 355
  • [25] Intensity modulated radiotherapy for high risk prostate cancer based on sentinel node optimized target volume definition
    Ganswindt, U
    Paulsen, F
    Glocker, S
    Birkner, M
    Alber, M
    Corvin, S
    Anastasiadis, A
    Eichhorn, K
    Bares, R
    Bamberg, M
    Budach, W
    Belka, C
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S320 - S320
  • [26] Intensity modulated radiotherapy for high risk prostate cancer based on sentinel node optimized target volume definition
    Ganswindo, U.
    Paulsen, F.
    Glocker, S.
    Birkner, M.
    Alber, M.
    Corvin, S.
    Bares, R.
    Budach, W.
    Bamberg, M.
    Belka, C.
    EJC SUPPLEMENTS, 2005, 3 (02): : 236 - 236
  • [27] 18F-choline (FCH) PET-CT (PET) in evaluation of patients (pts) with biochemical relapse from prostate cancer
    Rensi, Marco
    Giacomuzzi, Francesco
    Geatti, Onelio
    Capobianco, Decio
    Di Gregorio, Fernando
    Englaro, Emanuela
    Ferretti, Guido
    Povolato, Michele
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [28] Head To Head Comparison Of 18f-fch And 18f-psma-1007 Pet/ct In Biochemically Relapsed Prostate Cancer Patients Preliminary Results
    Witkowska-Patena, E.
    Gizewska, A.
    Dziuk, M.
    Misko, J.
    Budzynska, A.
    Walecka-Mazur, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S446 - S447
  • [29] Comparative Effectiveness of [18F]-Fluorocholine PET-CT and Pelvic MRI With Diffusion-Weighted Imaging for Staging in Patients With High-Risk Prostate Cancer
    Pinaquy, Jean-Baptiste
    De Clermont-Galleran, Henri
    Pasticier, Gilles
    Rigou, Gerald
    Alberti, Nicolas
    Hindie, Elif
    Mokrane, Yacoub
    Fernandez, Philippe
    PROSTATE, 2015, 75 (03): : 323 - 331
  • [30] Variability of radiotherapy volume delineation: PSMA PET/MRI and MRI based clinical target volume and lymph node target volume for high-risk prostate cancer
    Liu, Lin-Lin
    Zhu, Lei-Lei
    Lu, Zhen-Guo
    Sun, Jun-Die
    Zhao, Jun
    Wang, Hai-Feng
    Xiang, Zuo-Lin
    CANCER IMAGING, 2023, 23 (01)
12345